Overview
Ataxia-tapetoretinal degeneration syndrome is a very rare inherited condition that combines two main problems: progressive difficulty with coordination and balance (called ataxia) and gradual breakdown of the retina at the back of the eye (called tapetoretinal degeneration or retinal dystrophy). The ataxia part of this condition is caused by damage to the cerebellum, the part of the brain that controls smooth, coordinated movements. Over time, people with this syndrome may find it increasingly hard to walk, maintain balance, and perform fine motor tasks like writing or buttoning clothes. The retinal degeneration leads to progressive vision loss, which may start with difficulty seeing in dim light (night blindness) and loss of side vision, eventually affecting central vision as well. This syndrome belongs to a group of conditions sometimes referred to as spinocerebellar ataxia with retinal degeneration. It may also overlap with conditions historically described under names like Boucher-Neuhäuser syndrome or similar ataxia-retinal degeneration combinations, depending on the specific genetic cause. Because it is so rare, the medical understanding of this condition continues to evolve. There is currently no cure for ataxia-tapetoretinal degeneration syndrome. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy can help preserve mobility, occupational therapy supports daily activities, and low-vision aids and services can help people adapt to vision loss. Regular monitoring by both neurologists and eye specialists is important to track disease progression and adjust care as needed.
Key symptoms:
Progressive difficulty with balance and coordinationUnsteady walking (gait ataxia)Night blindnessLoss of peripheral (side) visionProgressive vision lossSlurred speechDifficulty with fine motor tasks like writingInvoluntary eye movements (nystagmus)Muscle stiffness or spasticityFatigueDifficulty swallowing in advanced stagesReduced reflexes
Clinical phenotype terms (9)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Ataxia-tapetoretinal degeneration syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ataxia-tapetoretinal degeneration syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ataxia-tapetoretinal degeneration syndrome.
Community
No community posts yet. Be the first to share your experience with Ataxia-tapetoretinal degeneration syndrome.
Start the conversation →Latest news about Ataxia-tapetoretinal degeneration syndrome
No recent news articles for Ataxia-tapetoretinal degeneration syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic testing should be done to confirm the diagnosis?,How quickly is the disease likely to progress in my case?,What therapies can help me maintain my balance and mobility for as long as possible?,Are there any clinical trials or research studies I could participate in?,What low-vision services and aids are available to help with my vision loss?,Should my family members be tested for this condition?,What should I watch for that would require urgent medical attention?
Common questions about Ataxia-tapetoretinal degeneration syndrome
What is Ataxia-tapetoretinal degeneration syndrome?
Ataxia-tapetoretinal degeneration syndrome is a very rare inherited condition that combines two main problems: progressive difficulty with coordination and balance (called ataxia) and gradual breakdown of the retina at the back of the eye (called tapetoretinal degeneration or retinal dystrophy). The ataxia part of this condition is caused by damage to the cerebellum, the part of the brain that controls smooth, coordinated movements. Over time, people with this syndrome may find it increasingly hard to walk, maintain balance, and perform fine motor tasks like writing or buttoning clothes. The r
How is Ataxia-tapetoretinal degeneration syndrome inherited?
Ataxia-tapetoretinal degeneration syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Ataxia-tapetoretinal degeneration syndrome?
4 specialists and care centers treating Ataxia-tapetoretinal degeneration syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.